Recent Quarter Total Invested
$107.53 B
Recent Quarter Institutional Ownership Percentage
89.61%
Total Invested of Last Quarter
$109.97 B
Ownership Percentage of Last Quarter
91.05%
Vertex Pharmaceuticals Incorporated Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPITAL WORLD INVESTORS | 11/13/2024 | 26.81 M | $12.47 B | 0.38% | 10.39% |
| VANGUARD GROUP INC | 11/13/2024 | 23.16 M | $10.77 B | 0.80% | 8.98% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 21.79 M | $10.13 B | 100.00% | 8.44% |
| STATE STREET CORP | 11/14/2024 | 11.82 M | $5.50 B | 0.77% | 4.58% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 11/13/2024 | 9.00 M | $4.19 B | 5.42% | 3.49% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 7.37 M | $3.43 B | 2.10% | 2.86% |
| JPMORGAN CHASE & CO | 11/08/2024 | 6.93 M | $3.22 B | 4.98% | 2.69% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 5.94 M | $2.75 B | -6.16% | 2.30% |
| JENNISON ASSOCIATES LLC | 11/08/2024 | 5.55 M | $2.58 B | 18.11% | 2.15% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 4.80 M | $2.23 B | 17.20% | 1.86% |
| AMUNDI | 11/13/2024 | 3.76 M | $1.73 B | 7.28% | 1.46% |
| LOOMIS SAYLES & CO L P | 11/13/2024 | 3.07 M | $1.43 B | -2.35% | 1.19% |
| MORGAN STANLEY | 11/14/2024 | 3.04 M | $1.41 B | -6.76% | 1.18% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 11/12/2024 | 2.91 M | $1.35 B | 5.82% | 1.13% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 2.61 M | $1.21 B | 1.42% | 1.01% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 2.52 M | $1.17 B | 4.14% | 0.98% |
| LEGAL & GENERAL GROUP PLC | 11/14/2024 | 2.30 M | $1.07 B | -4.91% | 0.89% |
| CLEARBRIDGE INVESTMENTS, LLC | 11/12/2024 | 1.97 M | $917.16 M | -5.68% | 0.76% |
| INVESCO LTD. | 11/12/2024 | 1.94 M | $903.93 M | 7.81% | 0.75% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 1.87 M | $870.55 M | -8.90% | 0.73% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 1.79 M | $830.97 M | -2.77% | 0.69% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 1.77 M | $822.27 M | -20.06% | 0.69% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 1.63 M | $758.77 M | 4.16% | 0.63% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.63 M | $756.38 M | 1.27% | 0.63% |
| ROYAL BANK OF CANADA | 11/14/2024 | 1.57 M | $729.08 M | -6.78% | 0.61% |
| EDGEWOOD MANAGEMENT LLC | 11/12/2024 | 1.55 M | $719.19 M | 7,876.32% | 0.60% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.36 M | $631.83 M | -34.13% | 0.53% |
| HARDING LOEVNER LP | 11/14/2024 | 1.15 M | $536.08 M | -2.68% | 0.45% |
| DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 11/14/2024 | 1.04 M | $482.40 M | -4.95% | 0.40% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 11/13/2024 | 967,851 | $450.13 M | -4.37% | 0.38% |
| BARCLAYS PLC | 11/19/2024 | 939,336 | $436.86 M | 11.08% | 0.36% |
| VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 938,051 | $435.85 M | -36.73% | 0.36% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 830,220 | $386.12 M | 1.45% | 0.32% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 789,220 | $367.05 M | -1.88% | 0.31% |
| UBS GROUP AG | 11/14/2024 | 774,215 | $360.07 M | 30.26% | 0.30% |
| SWISS NATIONAL BANK | 11/07/2024 | 766,000 | $356.25 M | 0.16% | 0.30% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 11/05/2024 | 672,098 | $312.58 M | 1.01% | 0.26% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 647,808 | $301.27 M | -2.29% | 0.25% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 622,225 | $289.38 M | -1.79% | 0.24% |
| SWEDBANK AB | 10/11/2024 | 578,513 | $269.05 M | -13.16% | 0.22% |
| FIRST TRUST ADVISORS LP | 11/13/2024 | 575,032 | $267.44 M | 182.79% | 0.22% |
| BELLEVUE GROUP AG | 11/14/2024 | 571,406 | $265.75 M | -3.72% | 0.22% |
| BANK OF MONTREAL /CAN/ | 11/13/2024 | 557,217 | $257.92 M | 8.95% | 0.22% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 11/12/2024 | 550,273 | $255.92 M | 6.77% | 0.21% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 522,205 | $241.72 M | 3.60% | 0.20% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 518,003 | $240.48 M | -8.05% | 0.20% |
| NATIONAL PENSION SERVICE | 10/30/2024 | 511,047 | $237.68 M | 10.70% | 0.20% |
| DEKABANK DEUTSCHE GIROZENTRALE | 10/24/2024 | 506,457 | $233.37 M | 0.99% | 0.20% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 484,813 | $225.48 M | -17.31% | 0.19% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 480,861 | $223.12 M | -10.31% | 0.19% |
Vertex Pharmaceuticals Incorporatedinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of VRTX shares?
During the previous two years, 2014 institutional investors and hedge funds held shares of Vertex Pharmaceuticals Incorporated. The most heavily invested institutionals were:
Capital World Investors: 26.81 M
VANGUARD GROUP INC: 23.16 M
BlackRock Funding, Inc. /DE: 21.79 M
STATE STREET CORP: 11.82 M
Capital Research Global Investors: 9 M
ALLIANCEBERNSTEIN L.P.: 7.37 M
-
What percentage of Vertex Pharmaceuticals Incorporated stock is owned by institutional investors?
89.61% of Vertex Pharmaceuticals Incorporated stock is owned by institutional investors.
-
How much institutional buying is happening at VRTX ?
Institutional investors have bought a total of 278.21 M shares in the last 24 months. This purchase volume represents approximately $129.09 B in transactions.